Pomerantz LLP Alerts Shareholders to Investor Suit Involving aTyr Pharma, Inc. – ATYR
NEW YORK CITY, NY / ACCESS Newswire / November 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ:ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are […]